Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Covance Labs Relocates Unit to Chantilly
Covance Laboratories will relocate its immunochemistry group from Vienna, Va., to a new laboratory under development at the Avion Tech Center III Park in Chantilly. Developer of the project is Biotech Services Group, the subsidiary of Scheer Partners that focuses on life science and biotech facilities. The new building will provide R&D labs and walk-in cold rooms in a 24,000-sf single-story structure.
Associates of Cape Cod Builds Diagnostics Production Facility
Associates of Cape Cod Inc. (ACCI) is building a new 79,000-sf FDA-validated production facility for diagnostics in the Falmouth Technology Park. ACCI manufactures endotoxin diagnostic assays extracted from the blood of horseshoe crabs. Laboratories will feature state-of-the-art technology. The cleanroom production areas include Class 100 formulation and filling suites, accessible through airlocks. The production process and facilities will be fully validated in accordance with FDA cGMP requirements.
Technology Commercialization Center Developed in Chicago
The Technology Commercialization Center, a $12-million project of the Illinois Medical District Commission, has been awarded to Knight Advanced Technology, the architecture/engineering subsidiary of Lester B. Knight & Associates. The 62,000-sf Center is envisioned as a “graduate” laboratory facility for biotechnology and other technology-based start-up companies that have outgrown an incubator laboratory setting. The project will be built at Chicago Technology Park.
Howard Hughes Medical Institute Plans Biomedical R&D Complex
The Howard Hughes Medical Institute has plans for a $500-million biomedical R&D complex at Janelia Farm in Ashburn. Bioinformatics, biomedical imaging, and gene protein research will be conducted at the facility, which will accommodate more than 300 scientists and support staff. Dormitories will provide accommodations for visiting researchers. Construction at the 281-acre site is scheduled to begin in 2003; completion is scheduled for late 2005.
Immunex Breaks Ground on the Helix Project
Immunex Corporation broke ground in January 2001 on the Helix Project—a new $750-million research and technology center—on a 29-acre parcel of undeveloped industrial land in Seattle. The facility will consolidate Immunex’s Seattle employees and will accommodate approximately 1,700 employees. Phase I of the center totals 1.1 million gsf and is scheduled for completion in fall/winter 2003.